KRSNAA DIAGNOSTICS LTD Intrinsic Value
KRSNAA · Healthcare Services · Current price ₹540
Is KRSNAA DIAGNOSTICS LTD undervalued?
DocStoX estimates the fair value of KRSNAA DIAGNOSTICS LTD at ₹669 per share, versus the current market price of ₹540. That puts the stock about +23.9% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹288), Relative P/E (₹1,571), Graham floor (₹418). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹288 (bear) to ₹669 (base) to ₹1,571 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹540 versus an intrinsic value of ₹669, KRSNAA DIAGNOSTICS LTD currently offers +23.9% of margin.
More on KRSNAA DIAGNOSTICS LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.